The effect of vaginal probiotic products in eliminating Human Papillomavirus

Not Applicable

• Conditions: human papillomavirus (HPV).; Papillomavirus as the cause of diseases classified elsewhere; B97.7

• Registration Number: IRCT20130812014333N200
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 54

Inclusion Criteria

Informed consent
Age 21-65 years
married
being in the follicular period of the menstrual cycle; Not having intercourse and not washing the vagina in the last 48 hours

Exclusion Criteria

Pregnant, lactating and smoking women
People who are considered sick based on clinical diagnosis but whose test results are negative
Using vaginal drugs such as creams, suppositories and vaginal disinfectants in the last 48 hours
Suffering from certain diseases such as liver, heart, kidney disease, diabetes, central nervous system diseases, blood dyscrasias, immune system defects and known sexually transmitted diseases.
Use of broad-spectrum antibiotics, antiprostaglandins, hormonal and immunosuppressive drugs, alcohol, and anticoagulant drugs during the last month

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Wet smear. Timepoint: 6 months after the start of the study. Method of measurement: Pap smear test.